KRAS G12C inhibitor 19

CAS No. 2649788-46-3

KRAS G12C inhibitor 19( —— )

Catalog No. M35195 CAS No. 2649788-46-3

KRAS G12C inhibitor 19 is a potent KRAS G12C inhibitor that demonstrates anti-tumor activity in cellular assays and inhibits tumor growth .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 186 In Stock
10MG 280 In Stock
25MG 543 In Stock
50MG 761 In Stock
100MG 1051 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    KRAS G12C inhibitor 19
  • Note
    Research use only, not for human use.
  • Brief Description
    KRAS G12C inhibitor 19 is a potent KRAS G12C inhibitor that demonstrates anti-tumor activity in cellular assays and inhibits tumor growth .
  • Description
    KRAS G12C inhibitor 19 is a potent inhibitor of KRAS G12C. KRAS G12C inhibitor 19 significantly inhibits tumor growth (extracted from patent WO2021118877A1).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Kras
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2649788-46-3
  • Formula Weight
    528.96
  • Molecular Formula
    C25H19ClF2N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (236.31 mM; Ultrasonic )
  • SMILES
    C(#N)C=1C2=C(C=CC(F)=C2SC1N)C=3C(Cl)=C4C(=CC3F)C(=O)N5[C@@](CCO4)(CN(C(C=C)=O)CC5)[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Serge Louis Boulet, et al. Kras g12c inhibitors. Patent WO2021118877A1.
molnova catalog
related products
  • 7-Methoxy-4-methylco...

    7-Methoxy-4-methylcoumarin is an inhibitor of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4.

  • 1,16-Hexadecanediol

    1,16-Hexadecanediol has low toxicity and can be used to make resins and nanomaterials.

  • BMf-BH3

    BMf-BH3 belongs to the Bcl-2 apoptosis mediator family. This peptide belongs to the Bcl-2 apoptosis mediator family. Bmf is a key player in histone deacetylase (HDAC) inhibition, which alters the balance between deacetylation and acetylation.